"Designing Growth Strategies is in our DNA"

Cardiovascular Drugs Market Size, Share & Industry Analysis, By Drug Type (Antihypertensive, Antihyperlipidemic, Anticoagulants, Antiplatelet Drugs, Others), By Disease Indication (Hypertension, Hyperlipidemia, Coronary Artery Disease, Arrhythmia, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019 -2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100379

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Cardiovascular Diseases by Key Countries
    2. Pipeline Analysis
    3. Key Industry Developments Such as Mergers & Acquisitions
    4. New Product Launches
    5. The Regulatory Scenario in Key Countries
    6. Reimbursement Scenario by Key Countries
    7. Advances in R&D for Novel Therapeutics
  5. Global Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis, Insights and Forecast – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Cardiovascular Drugs Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Drug Type
      1. Antihypertensive
      2. Antihyperlipidemic
      3. Anticoagulants
      4. Antiplatelet Drugs
      5. Others
    3. Market Analysis – By Disease Indication
      1. Hypertension
      2. Hyperlipidemia
      3. Coronary Artery Disease
      4. Arrhythmia
      5. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
      4. Others
    5. Market Analysis – By Country/ sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Pfizer Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Bayer AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. AstraZeneca
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Sanofi
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Gilead Sciences, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      11. Other Prominent Players
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

 

Read Less

Figure 1:  Global Cardiovascular Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 2:  Global Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018 & 2026

Figure 3:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Antihypertensive, 2015-2026

Figure 4:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Antihyperlipidemic, 2015-2026

Figure 5:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Anticoagulants, 2015-2026

Figure 6:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Antiplatelet Drugs, 2015-2026

Figure 7:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 8:  Global Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018 & 2026

Figure 9:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Hypertension, 2015-2026

Figure 10:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Hyperlipidemia, 2015-2026

Figure 11:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Coronary Artery Disease, 2015-2026

Figure 12:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Arrhythmia, 2015-2026

Figure 13:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 14:  Global Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018 & 2026

Figure 15:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Hospital Pharmacies, 2015-2026

Figure 16:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Retail Pharmacies, 2015-2026

Figure 17:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Online Pharmacies, 2015-2026

Figure 18:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Others, 2015-2026

Figure 19:  Global Cardiovascular Drugs Market Forecast (US$ Mn), by Mod5, 2015-2026

Figure 20:  Global Cardiovascular Drugs Market Value (US$ Mn), by Region, 2018 & 2026

Figure 21:  North America Cardiovascular Drugs Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 22:  North America Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018

Figure 23:  North America Cardiovascular Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 24:  North America Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018

Figure 25:  North America Cardiovascular Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 26:  North America Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 27:  North America Cardiovascular Drugs Market Value (US$ Mn), By Country, 2018 & 2026

Figure 28:  North America Cardiovascular Drugs Market Value Share (%), By Country, 2018

Figure 29:  Europe Cardiovascular Drugs Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 30:  Europe Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018

Figure 31:  Europe Cardiovascular Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 32:  Europe Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018

Figure 33:  Europe Cardiovascular Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 34:  Europe Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 35:  Europe Cardiovascular Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 36:  Europe Cardiovascular Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 37:  Asia Pacific Cardiovascular Drugs Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 38:  Asia Pacific Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018

Figure 39:  Asia Pacific Cardiovascular Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 40:  Asia Pacific Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018

Figure 41:  Asia Pacific Cardiovascular Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 42:  Asia Pacific Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 43:  Asia Pacific Cardiovascular Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 44:  Asia Pacific Cardiovascular Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 45:  Latin America Cardiovascular Drugs Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 46:  Latin America Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018

Figure 47:  Latin America Cardiovascular Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 48:  Latin America Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018

Figure 49:  Latin America Cardiovascular Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 50:  Latin America Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 51:  Latin America Cardiovascular Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 52:  Latin America Cardiovascular Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 53:  Middle East & Africa Cardiovascular Drugs Market Value (US$ Mn), by Drug Type, 2018 & 2026

Figure 54:  Middle East & Africa Cardiovascular Drugs Market Value Share (%), by Drug Type, 2018

Figure 55:  Middle East & Africa Cardiovascular Drugs Market Value (US$ Mn), by Disease Indication, 2018 & 2026

Figure 56:  Middle East & Africa Cardiovascular Drugs Market Value Share (%), by Disease Indication, 2018

Figure 57:  Middle East & Africa Cardiovascular Drugs Market Value (US$ Mn), by Distribution Channel, 2018 & 2026

Figure 58:  Middle East & Africa Cardiovascular Drugs Market Value Share (%), by Distribution Channel, 2018

Figure 59:  Middle East & Africa Cardiovascular Drugs Market Value (US$ Mn), By Country/ Sub-region, 2018 & 2026

Figure 60:  Middle East & Africa Cardiovascular Drugs Market Value Share (%), By Country/ Sub-region, 2018

Figure 61:  Global Cardiovascular Drugs Market Share (%), By Company, 2018

Table 1:  Global Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015–2026

Table 2:  Global Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2026

Table 3:  Global Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 4:  Global Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Region, 2015-2026

Table 5:  North America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 6:  North America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 7:  North America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 8:  North America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, By Country, 2015-2026

Table 9:  Europe Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 10:  Europe Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 11:  Europe Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 12:  Europe Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 13:  Asia Pacific Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 14:  Asia Pacific Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 15:  Asia Pacific Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 16:  Asia Pacific Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 17:  Latin America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 18:  Latin America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 19:  Latin America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 20:  Latin America Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Table 21:  Middle East & Africa Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Drug Type, 2015-2026

Table 22:  Middle East & Africa Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015-2026

Table 23:  Middle East & Africa Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015-2026

Table 24:  Middle East & Africa Cardiovascular Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2015-2026

Cardiovascular Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase